StockTipsArenaBeta

BUY Biocon Ltd — Prakash Gaba

BUYBiocon Ltd
Biocon share price target & all analyst calls

byPrakash GabaHorizon: NA (inferred Swing (≤2wk))17 Sept 2026via CNBC Awaaz.

Entry₹376.3Inferred
Target₹390
Total upside +3.64% (call closed)
Stop loss₹370-1.67% risk
Exit₹39021 Sept 2026, 9:35 am
Target hit+3.64%0.00%upside left
Follow Prakash Gaba for new calls(32% target hit, 322 closed calls)Get alertsWatch BIOCON for new buy/sell callsGet alertsSee 1 active Swing call on BIOCONSee 204 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 21 Sept 2026
10 supporting2 neutral2 opposing
Supports the BUY call (10)

Biocon's subsidiary received a positive opinion from EMA's CHMP for its Pertuzumab biosimilar (Pebrilzo) for HER2-positive breast cancer treatment. This is the first biosimilar to receive such recomme

BSE · Company Update·21 Sept · today

(opens in new tab)

Biocon's biosimilar Pertuzumab has received a positive recommendation from the EMA's CHMP under a new tailored clinical approach, marking a significant regulatory milestone.

NSE · Press Release·21 Sept · today

(opens in new tab)

3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·19 Sept · 2d ago

Biocon shares rise 3% after Rs 638-crore block deal; Active Pine likely seller

NewsEt-Markets·9 Sept · 2w ago

(opens in new tab)

Biocon shares gain nearly 3% after equity worth ₹630 crore changes hands in block deal

NewsCnbc-Tv18·9 Sept · 2w ago

(opens in new tab)
Neutral / worth noting (2)

Biocon Block Deal: Active Pine likely to sell 1.66 crore shares at ₹385 per share

NewsCnbc-Tv18·8 Sept · 2w ago

(opens in new tab)

Biocon Block Deal: True North Likely To Sell Rs 640-Crore Stake, Sources Say

NewsNdtv-Profit·8 Sept · 2w ago

(opens in new tab)
Weighs against the BUY call (2)

US Drug Tariff: 15 Pharma Stocks Likely to Be Impacted by Trump’s New Tariff Plan

NewsGoogle News·16 Sept · 4d ago

(opens in new tab)

Biocon shares: Active Pine may divest up to 1% equity worth Rs 638 crore via block deal

NewsEt-Markets·8 Sept · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Biocon

All analyst calls on Biocon

More from Prakash Gaba

Every call and its outcome